Articles Posted in compounding pharmacy

Published on:

Our Boston product liability lawyers recently discussed the arrest of NECC owners and employees in connection with the meningitis outbreak that occurred in 2012. The outbreak, which left 64 dead and caused more than 750 people to contract meningitis, was traced to contaminated steroids from the New England Compounding Center. The contamination occurred because basic safety protocols were not followed when the drugs were being compounded and packaged. attorney.jpg

Following the public health crisis due to the contaminated steroids, NECC went bankrupt. This left many victims turning to suing sister companies of NECC to try to recover compensation for their monetary and non-economic damages. It also left the NECC owners and employees without any consequences to face for what they had done. Now, however, the arrest of the owners and of some high level employees at the pharmacy could change things.
Continue reading

Published on:

In 2012, a meningitis outbreak was traced to a New England compounding facility. As our Boston product liability lawyers wrote at the time, multiple drugs were linked to the meningitis outbreak. DWI Arrest.jpg

More than two years later, many of the victims and their family members are still trying to get justice from those responsible. Separate from the civil lawsuits, prosecutors have also been investigating what laws were broken and whether criminal charges were appropriate. Now, CBS Boston has announced that 14 people were arrested for their role in causing this devastating public health crisis that affected so many victims throughout Boston and the rest of the United States.
Continue reading

Published on:

According to a recent news article from CBS Boston, the founders of a Framingham compounding pharmacy and 12 other employees have been charged with racketeering and second-degree murder.

caduceus-1219484-m.jpgCourt papers indicated the compounding pharmacy was only licensed to manufacture small numbers of specific drugs for individual patients. This is the same pharmacy that was linked to a 2012 meningitis outbreak allegedly caused by tainted steroids made by defendants. In that incident, 64 people died and 750 more became seriously ill after taking the drugs.

As part of an investigation into this defective drug manufacturing incident, authorities found records filled with obviously fake names of patients such as “Bud Weiser,” “Filet O’fish,” and “Baby Jesus.” There were instructions by company founders that the names used in official logs should resemble real names and not be obviously false, though it appears employees did not follow this advice. The fake names are part of an alleged plan to defraud the FDA and avoid reporting requirements.
Continue reading

Published on:

In previous posts, we have discussed the dangerous nature of compounding pharmacies, including the lack of federal regulation, the risk of counterfeit, and the general threat to consumers in Massachusetts and nationwide. Last year a meningitis outbreak and other events involving compounded drugs lead to serious infection and in many cases resulted in death. Since the outbreak, Congress has been working to pass comprehensive legislation to give authority to the FDA to properly regulate compounded drugs. According to an official statement from the FDA, a new law may help to properly regulate the industry and keep consumers safe.

injection.jpg

The risk of dangerous or defective drugs produced by compounding pharmacies is significant. Our Boston injury attorneys are dedicated to protecting the rights of individual clients as well as consumers nationwide. We will take necessary action against compounding pharmacies and are committed to staying abreast of legal developments that may have a positive impact on the health of our nation. The Drug Quality and Security Act is a positive step in this direction.
Continue reading

Published on:

It’s been almost a year since a fungal meningitis outbreak swept the country, with officials later tracing the cases to Massachusetts compounding pharmacies.
injection.jpg
compounding pharmacy injuries continue as lawmakers and public officials begin drawing a harder line with regard to regulation of these facilities.

Unfortunately, despite numerous promises, those regulatory actions have been slow to form, even as more compounding pharmacy drugs face recall, continuing to cause serious illness and even death.
Continue reading